Keyphrases
Sphingosine-1-phosphate
100%
Sphingosine Kinase 1 (SphK1)
100%
Chemotherapy Resistance
100%
Lyase
100%
Sphingosine
100%
Gastroesophageal Cancer
100%
Drug Resistance
57%
Cytotoxic Drugs
57%
Chemotherapy
42%
Cisplatin
42%
IC50
42%
Gene Expression
28%
Resistance Mechanisms
28%
Sphingolipids
28%
Drug-resistant Cancer Cell Lines
28%
Safingol
28%
Gastric Cancer Cell Lines
28%
Clinical Practice
14%
Metabolism
14%
Quantitative PCR
14%
Immunohistochemistry
14%
Cancer Patients
14%
Patient Survival
14%
Human Trials
14%
Oxaliplatin
14%
Differential Expression
14%
Differentially Expressed
14%
Docetaxel
14%
Tumor Metabolism
14%
Resistance to Chemotherapy
14%
Protein Expression
14%
Pharmacological Inhibitors
14%
Surgery Alone
14%
New Targets
14%
Predictive Biomarker
14%
Lysosome
14%
Exon
14%
Affymetrix
14%
Metabolic Pathway Analysis
14%
P53 Pathway
14%
New Biomarkers
14%
Sphingolipid Metabolism
14%
Chemoresistant
14%
Sphingosine Kinase Inhibitor
14%
Tumor Specimens
14%
Cell Line Models
14%
Gene Lists
14%
Glycosphingolipids
14%
Cancer Cell Line Panel
14%
Lead Target
14%
New Cell Line
14%
Lysosomal Compartment
14%
Over-represented Pathways
14%
Novel Chemotherapy
14%
Medicine and Dentistry
Malignant Neoplasm
100%
Sphingosine 1 Phosphate
100%
Sphingosine Kinase 1
100%
Lyase
100%
Sphingosine
100%
Cell Line
62%
Drug Resistance
50%
Cytotoxic Agent
50%
IC50
37%
Cisplatin
37%
Neoplasm
25%
Biological Marker
25%
Gene Expression
25%
Sphingolipid
25%
Safingol
25%
Drug-Resistant Cell Line
25%
Gastric Cancer Cell Line
25%
Messenger RNA
25%
Immunohistochemistry
12%
Metabolite
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Cancer
12%
Lysosome
12%
Mediator
12%
Protein Expression
12%
High-Performance Liquid Chromatography
12%
Oxaliplatin
12%
Exon
12%
Protein P53
12%
Patient History of Chemotherapy
12%
Docetaxel
12%
Sphingolipid Metabolism
12%
Glycosphingolipid
12%
INIS
phosphates
100%
cancer
100%
drugs
100%
regulations
100%
chemotherapy
100%
kinases
100%
lyases
100%
genes
62%
patients
50%
tumors
25%
surgery
25%
biological markers
25%
metabolism
25%
messenger-rna
25%
proteins
25%
humans
12%
comparative evaluations
12%
metabolites
12%
inhibition
12%
panels
12%
pcr
12%
investigations
12%
compartments
12%
biological pathways
12%
exons
12%
lysosomes
12%
hplc
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Chemotherapy
100%
Lyase
100%
Sphingosine 1 Phosphate
100%
Sphingosine Kinase 1
100%
Sphingosine
100%
Drug Resistance
50%
Cytotoxic Agent
50%
Cisplatin
37%
IC50
37%
Sphingolipid
37%
Neoplasm
25%
Biological Marker
25%
Abdominal Cancer
25%
Safingol
25%
Messenger RNA
25%
Protein P53
12%
High Performance Liquid Chromatography
12%
Oxaliplatin
12%
Patient History of Chemotherapy
12%
Docetaxel
12%
Glycosphingolipid
12%
Biochemistry, Genetics and Molecular Biology
Lyase
100%
Sphingosine
100%
Sphingosine Kinase 1
100%
Sphingosine-1-Phosphate
100%
Drug Resistance
50%
Cisplatin
37%
IC50
37%
Gene Expression
25%
Cancer Cell
25%
Messenger RNA
25%
Sphingolipid
25%
Metabolic Pathway
12%
Metabolite
12%
Lysosome
12%
Protein Expression
12%
Mediator
12%
High-Performance Liquid Chromatography
12%
Exon
12%
P53
12%
Quantitative Reverse Transcription Polymerase Chain Reaction
12%
Sphingolipid Metabolism
12%
Glycosphingolipid
12%
Differentially Expressed Gene
12%
Immunology and Microbiology
Cell Line
100%
Drug Resistance
80%
IC50
60%
Gene Expression
40%
Gastric Cancer Cell Line
40%
Drug-Resistant Cell Line
40%
Quantitative Reverse Transcription Polymerase Chain Reaction
20%
Metabolite
20%
Protein Expression
20%
Mediator
20%
High Performance Liquid Chromatography
20%
P53
20%
Lysosome
20%
Exon
20%
Sphingolipid Metabolism
20%